Clinical Trial Update: Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial of unfractionated heparin for acute chest syndrome in sickle cell disease was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Craig Seaman | Conditions: Acute Chest Syndrome, Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-07-16